Works matching IS 1025496X AND DT 2022 AND VI 27 AND IP 37

Results: 3

Emergence of genetically linked vaccine-originated poliovirus type 2 in the absence of oral polio vaccine, Jerusalem, April to July 2022.
Published in:
Eurosurveillance (15607917), 2022, v. 27, n. 37, p. 2, doi. 10.2807/1560-7917.ES.2022.27.37.2200694
By:
- Zuckerman, Neta S.;
- Bar-Or, Itay;
- Sofer, Danit;
- Bucris, Efrat;
- Morad, Hagar;
- Shulman, Lester M.;
- Levi, Nofar;
- Weiss, Leah;
- Aguvaev, Irina;
- Cohen, Zvi;
- Kestin, Klil;
- Vasserman, Rinat;
- Elul, Michal;
- Fratty, Ilana S.;
- Geva, Miranda;
- Wax, Marina;
- Erster, Oran;
- Yishai, Ruth;
- Hecht-Sagie, Lior;
- Alroy-Preis, Sharon
Publication type:
Article
Seroconversion rate and socio-economic and ethnic risk factors for SARS-CoV-2 infection in children in a population-based cohort, Germany, June 2020 to February 2021.
Published in:
Eurosurveillance (15607917), 2022, v. 27, n. 37, p. 14, doi. 10.2807/1560-7917.ES.2022.27.37.2101028
By:
- Brinkmann, Folke;
- Diebner, Hans H.;
- Matenar, Chantal;
- Schlegtendal, Anne;
- Eitner, Lynn;
- Timmesfeld, Nina;
- Maier, Christoph;
- Lücke, Thomas
Publication type:
Article
COVID-19 mRNA vaccine effectiveness (second and first booster dose) against hospitalisation and death during Omicron BA.5 circulation: cohort study based on electronic health records, Portugal, May to July 2022.
Published in:
Eurosurveillance (15607917), 2022, v. 27, n. 37, p. 8, doi. 10.2807/1560-7917.ES.2022.27.37.2200697
By:
- Kislaya, Irina;
- Machado, Ausenda;
- Magalhães, Sarah;
- Paula Rodrigues, Ana;
- Franco, Rafael;
- Pinto Leite, Pedro;
- Matias Dias, Carlos;
- Nunes, Baltazar
Publication type:
Article

Works matching IS 1025496X AND DT 2022 AND VI 27 AND IP 37

Emergence of genetically linked vaccine-originated poliovirus type 2 in the absence of oral polio vaccine, Jerusalem, April to July 2022.

Seroconversion rate and socio-economic and ethnic risk factors for SARS-CoV-2 infection in children in a population-based cohort, Germany, June 2020 to February 2021.

COVID-19 mRNA vaccine effectiveness (second and first booster dose) against hospitalisation and death during Omicron BA.5 circulation: cohort study based on electronic health records, Portugal, May to July 2022.